1Dr. P. Smits,T. Thien.Cardiovascular effects of sulphonylurea derivatives[J].Diabetologia.1995(1)
2Herlitz J,Malmberg K.How to improve the cardiac prognosis for diabetes[].Diabetes Care.1999
3Mahaffey KW,Granger CB,Toth CA,et al.Diabetic retinopathyshould not be a contraindication to thrombolytic therapy for acutemyocardial infarction:review of ocular hemorrhage incidence andlocation in the GUSTO- I trial.Global utilization of streptokinase andt- PA for occluded coronary arteries[].Journal of the American College of Cardiology.1997
4Aronson D,Rayfield EJ,Chesebro JH,et al.Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction[].Annals of Internal Medicine.1997
5Davis TM,Parsons RW,Broadhurst RJ,et al.Arrhythmias and mortality after myocardial infarction in diabetic patients, relationship to diabetes treatment[].Diabetes Care.1998
6Yudkin JS.Iusulin infustion in diabetic patients, with acute mgocardial infarction[].British Medical Journal.1997
7Chutkow WA,Simon MC,Le Beau MM,et al.Cloning, tissue expression, and chromosomal localiztion of SUR2, the putative drugbinding subunit of cardiac, skeletal muscle, and vascular KATP channels[].Diabetes.1996
8Laakso M.Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus.The Finnish Studies[].Annals of Internal Medicine.1996
9Borghi C,Ambrosioni E.Evidence-based medicine and ACE inhibition[].Journal of Cardiovascular Pharmacology.1998
10Chowdhury TA,Lasker SS.Elevated glycated haemoglobin in nondiabetic patients is associated with an increased mortality in myocardial infarction[].Postgraduate Medical Journal.1998
